Grover’s-like drug eruption in a patient with metastatic melanoma under ipilimumab therapy

BACKGROUND: Dermatologic toxicity is an important adverse effect of immune checkpoint inhibitors targeting cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) and programmed cell death 1 receptor (PD-1) or PD ligand 1 (PD-L1). Skin toxicity most commonly includes a maculopapular erythematous rash a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Koelzer, Viktor H., Buser, Tobias, Willi, Niels, Rothschild, Sacha I., Wicki, Andreas, Schiller, Peter, Cathomas, Gieri, Zippelius, Alfred, Mertz, Kirsten D.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4986338/
https://ncbi.nlm.nih.gov/pubmed/27532022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-016-0151-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados